Please login to the form below

Not currently logged in
Email:
Password:

Questcor Pharmaceuticals

This page shows the latest Questcor Pharmaceuticals news and features for those working in and with pharma, biotech and healthcare.

Ireland’s Mallinckrodt makes $1.3bn immunotherapy purchase

Ireland’s Mallinckrodt makes $1.3bn immunotherapy purchase

This includes the $5.6bn deal for Questcor Pharmaceuticals last year and its purchase of Cadence Pharmaceuticals for $1.3bn.

Latest news

  • Questcor MS drug wins new indication

    Questcor Pharmaceuticals has won US Food and Drug Administration approval of a new indication for its for HP Acthar Gel. ... Questcor Pharmaceuticals, which specialises in drugs for difficult-to-treat diseases, has won US Food and Drug Administration (FDA

  • The Pump House

    Hepatitis. China. Mecasermin rinfabate. Iplex (Insmed). Growth disorders. US. Methylphenidate. Methylin Chewable Tablets (Alliant Pharmaceuticals). ... Quazepam. (Questcor Pharmaceuticals). Insomnia. US. Risperidone. Generic risperidone (Actavis Group).

More from news
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest Intelligence

  • Pharma deals during April 2014 Pharma deals during April 2014

    All told 24% of its revenues will come from in consumer health, 62% pharmaceuticals and 14% vaccines. ... wholesale takeovers with deals in Devices (Biomet/ Zimmer Holdings, AccessClosure/ Cardinal Health; New Wave Surgical/ Covidien), Generics/

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

  • Questcor appoints SVP corporate strategic development Questcor appoints SVP corporate strategic development

    Michael Aldridge joins from Australian early development company Xenome. US biopharma Questcor Pharmaceuticals has named Michael Aldridge as its first senior VP, corporate strategic development. ... Development programmes that complement Acthar are also

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Real Science Communications

Real Science Communications is a scientific centre of excellence, infusing credibility and scientific rigour into the conversations around health and...

Latest intelligence

International Childhood Cancer Day 2019
The number of new cases per year is shocking but the journey and the outlooks have vastly improved. We've pulled together an infographic to show just what we mean with...
Immuno-oncology in 2019: the rapid evolution continues
Immunotherapy is pharma’s biggest growth driver – how will it develop in 2019?...
Mixing up Focus Groups
A nice spread of homogeneous participants in a focus groups are often a go to for reliable research outcomes but there's much to be said for mixing it up and...

Infographics